CS logo
small CS logo
Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik

Kufstein, Austria
Hospital in Kufstein
Endach 27, 6330 Kufstein

About Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


During the past decade, Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator, "Medical University of Vienna" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "University of Navarra" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

Clinical Trials Conditions at Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


According to Clinical.Site data, the most researched conditions in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik" are "Multiple Myeloma" (1 trials) and "Newly Diagnosed Multiple Myeloma" (1 trials). Many other conditions were trialed in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik" in a lesser frequency.

Clinical Trials Intervention Types at Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


Most popular intervention types in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Lenalidomide" (2 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials), "Dexamethasone Oral" (1 trials) and "Isatuximab-Irfc 20 MG/ML [Sarclisa]" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


The vast majority of trials in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik" are 2 trials for "All" genders.

Clinical Trials Status at Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik


Currently, there are NaN active trials in "Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".